SCPS:OTC-Scopus Biopharma Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.0011

Change

0.00 (0.00)%

Market Cap

USD 0.07M

Volume

943.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
NONOF Novo Nordisk A/S

N/A

USD 568.62B
CSLLY CSL Ltd

N/A

USD 89.31B
CMXHF CSL Limited

N/A

USD 89.27B
UCBJF UCB SA

N/A

USD 25.40B
UCBJY UCB SA ADR

N/A

USD 25.10B
ARGNF argenx SE

N/A

USD 22.28B
GNMSF Genmab A/S

N/A

USD 18.12B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 7.48B
WXIBF WuXi Biologics

N/A

USD 7.17B
WXXWY WuXi Biologics (Cayman) Inc

N/A

USD 7.17B

ETFs Containing SCPS

IEO 18.59 % 0.42 %

N/A

N/A
NRGD MicroSectors U.S. Big Oil.. 10.00 % 0.00 %

N/A

USD 0.07B
NRGU MicroSectors U.S. Big Oil.. 10.00 % 0.00 %

N/A

USD 2.47B
NRGO 10.00 % 0.00 %

N/A

N/A
NRGZ 10.00 % 0.00 %

N/A

N/A
YGRN 10.00 % 0.00 %

N/A

N/A
FRAK 8.73 % 0.54 %

N/A

N/A
FTXN First Trust Nasdaq Oil & .. 8.01 % 0.60 %

N/A

USD 0.22B
IYE iShares U.S. Energy ETF 8.00 % 0.42 %

N/A

USD 1.36B
FENY Fidelity® MSCI Energy In.. 7.32 % 0.08 %

N/A

USD 1.89B
JHME 6.90 % 0.48 %

N/A

N/A
NXF:CA First Asset Energy Giants.. 6.89 % 0.72 %

N/A

CAD 0.16B
NXF-B:CA CI Energy Giants Covered .. 6.89 % 0.00 %

N/A

CAD 0.02B
OILD MicroSectorsTM Oil & Gas .. 6.84 % 1.24 %

N/A

USD 0.01B
OILU MicroSectorsTM Oil & Gas .. 6.46 % 1.22 %

N/A

USD 0.04B
DIG ProShares Ultra Oil & Gas 6.43 % 0.95 %

N/A

USD 0.13B
DDG 5.83 % 0.95 %

N/A

N/A
FILL iShares MSCI Global Energ.. 5.10 % 0.39 %

N/A

USD 0.11B
ERYY 4.79 % 0.45 %

N/A

N/A
HUL-U:CA 4.46 % 0.00 %

N/A

N/A
HUL:CA 4.46 % 2.20 %

N/A

N/A
IGE 4.40 % 0.46 %

N/A

N/A
GASX 4.29 % 1.01 %

N/A

N/A
NANR SPDR S&P® North American.. 4.27 % 0.35 %

N/A

USD 0.56B
EQRR ProShares Equities for Ri.. 3.04 % 0.35 %

N/A

USD 0.02B
PVAL Putnam Focused Large Cap .. 2.87 % 0.29 %

N/A

USD 0.49B
FCUQ:CA Fidelity U.S. High Qualit.. 2.65 % 0.00 %

N/A

CAD 0.44B
FCQH:CA Fidelity U.S. High Qualit.. 2.64 % 0.43 %

N/A

CAD 0.05B
HEA:CA Horizons Enhanced Income .. 2.61 % 0.00 %

N/A

CAD 0.14B
HEA-U:CA Horizons Enhanced Income .. 2.61 % 0.00 %

N/A

CAD 0.03B
RFFC RiverFront Dynamic US Fle.. 2.49 % 0.52 %

N/A

USD 0.02B
QUAL 2.35 % 0.15 %

N/A

N/A
SIZE iShares MSCI USA Size Fac.. 2.35 % 0.15 %

N/A

USD 0.31B
GASL 1.45 % 1.19 %

N/A

N/A
GUSH Direxion Daily S&P Oil & .. 1.21 % 1.04 %

N/A

USD 0.51B
EQWL Invesco S&P 100 Equal Wei.. 1.15 % 0.25 %

N/A

USD 0.63B
TERM 0.88 % 0.64 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.65 % 0.40 %

N/A

CAD 0.35B
JIGB JPMorgan Corporate Bond R.. 0.39 % 0.14 %

N/A

USD 0.05B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

N/A

USD 0.40B
BWX SPDR® Bloomberg Internat.. 0.00 % 0.50 %

N/A

USD 0.86B
EBND SPDR® Bloomberg Emerging.. 0.00 % 0.41 %

N/A

USD 1.93B
MTUM 0.00 % 0.15 %

N/A

N/A
LSAF LeaderSharesTM AlphaFacto.. 0.00 % 0.75 %

N/A

USD 0.14B
TGED:CA TD Active Global Enhanced.. 0.00 % 0.00 %

N/A

CAD 0.27B
RSP Invesco S&P 500® Equal W.. 0.00 % 0.20 %

N/A

USD 53.38B
RYE 0.00 % 0.40 %

N/A

N/A
WIP SPDR® FTSE International.. 0.00 % 0.50 %

N/A

USD 0.39B
HPF:CA Energy Leaders Plus Incom.. 0.00 % 1.74 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -97.44% 3% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -97.44% 3% F 1% F
Trailing 12 Months  
Capital Gain -98.31% 6% D- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -98.31% 6% D- 3% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -62.49% 1% F N/A F
Dividend Return -62.49% 1% F N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.20% 71% C- 57% F
Risk Adjusted Return -151.67% 2% F 1% F
Market Capitalization 0.07M 16% F 10% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.